China National Medicines Corp Ltd (600511) - Cash Flow Conversion Efficiency
Based on the latest financial reports, China National Medicines Corp Ltd (600511) has a cash flow conversion efficiency ratio of -0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-540.00 Million ≈ $-79.02 Million USD) by net assets (CN¥19.93 Billion ≈ $2.92 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see China National Medicines Corp Ltd market cap and net worth for the company's overall valuation and market capitalisation.
China National Medicines Corp Ltd - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how China National Medicines Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
China National Medicines Corp Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of China National Medicines Corp Ltd ranked by their cash flow conversion efficiency. Explore how high is China National Medicines Corp Ltd's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Treasury Wine Estates Ltd
AU:TWE
|
0.030x |
|
Solusi Tunas Pratama Tbk
JK:SUPR
|
0.174x |
|
Data Patterns (India) Limited
NSE:DATAPATTNS
|
-0.032x |
|
WG Tech JiangXi Co Ltd
SHG:603773
|
0.044x |
|
Banc of California, Inc.
NYSE:BANC
|
0.051x |
|
SKC Co. Ltd
KO:011790
|
-0.121x |
|
Premium Brands Holdings Corporation
TO:PBH
|
-0.003x |
|
Doral Group Renewable Energy Resources Ltd
TA:DORL
|
0.011x |
Annual Cash Flow Conversion Efficiency for China National Medicines Corp Ltd (2001–2024)
The table below shows the annual cash flow conversion efficiency of China National Medicines Corp Ltd from 2001 to 2024. View China National Medicines Corp Ltd (600511) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥18.98 Billion ≈ $2.78 Billion |
CN¥1.66 Billion ≈ $242.78 Million |
0.087x | -43.78% |
| 2023-12-31 | CN¥17.53 Billion ≈ $2.57 Billion |
CN¥2.73 Billion ≈ $399.00 Million |
0.156x | +2.97% |
| 2022-12-31 | CN¥15.86 Billion ≈ $2.32 Billion |
CN¥2.40 Billion ≈ $350.48 Million |
0.151x | +10.76% |
| 2021-12-31 | CN¥14.36 Billion ≈ $2.10 Billion |
CN¥1.96 Billion ≈ $286.44 Million |
0.136x | +37.17% |
| 2020-12-31 | CN¥13.09 Billion ≈ $1.92 Billion |
CN¥1.30 Billion ≈ $190.48 Million |
0.099x | -31.95% |
| 2019-12-31 | CN¥12.16 Billion ≈ $1.78 Billion |
CN¥1.78 Billion ≈ $259.89 Million |
0.146x | +57.88% |
| 2018-12-31 | CN¥10.61 Billion ≈ $1.55 Billion |
CN¥981.65 Million ≈ $143.65 Million |
0.093x | -18.57% |
| 2017-12-31 | CN¥9.46 Billion ≈ $1.38 Billion |
CN¥1.07 Billion ≈ $157.23 Million |
0.114x | -22.81% |
| 2016-12-31 | CN¥4.02 Billion ≈ $587.79 Million |
CN¥591.25 Million ≈ $86.52 Million |
0.147x | +17.49% |
| 2015-12-31 | CN¥3.51 Billion ≈ $514.25 Million |
CN¥440.29 Million ≈ $64.43 Million |
0.125x | +47.68% |
| 2014-12-31 | CN¥2.58 Billion ≈ $377.65 Million |
CN¥218.94 Million ≈ $32.04 Million |
0.085x | +0.39% |
| 2013-12-31 | CN¥2.20 Billion ≈ $321.31 Million |
CN¥185.56 Million ≈ $27.15 Million |
0.085x | -15.00% |
| 2012-12-31 | CN¥1.87 Billion ≈ $273.56 Million |
CN¥185.87 Million ≈ $27.20 Million |
0.099x | +141.13% |
| 2011-12-31 | CN¥1.53 Billion ≈ $224.31 Million |
CN¥-370.56 Million ≈ $-54.22 Million |
-0.242x | -202.04% |
| 2010-12-31 | CN¥1.34 Billion ≈ $196.55 Million |
CN¥318.21 Million ≈ $46.56 Million |
0.237x | +0.56% |
| 2009-12-31 | CN¥1.08 Billion ≈ $158.49 Million |
CN¥255.18 Million ≈ $37.34 Million |
0.236x | -5.77% |
| 2008-12-31 | CN¥868.25 Million ≈ $127.05 Million |
CN¥217.10 Million ≈ $31.77 Million |
0.250x | +128.39% |
| 2007-12-31 | CN¥725.96 Million ≈ $106.23 Million |
CN¥79.48 Million ≈ $11.63 Million |
0.109x | -46.75% |
| 2006-12-31 | CN¥590.99 Million ≈ $86.48 Million |
CN¥121.50 Million ≈ $17.78 Million |
0.206x | +16.24% |
| 2005-12-31 | CN¥521.33 Million ≈ $76.29 Million |
CN¥92.20 Million ≈ $13.49 Million |
0.177x | +75.64% |
| 2004-12-31 | CN¥488.38 Million ≈ $71.47 Million |
CN¥49.18 Million ≈ $7.20 Million |
0.101x | +8868.91% |
| 2003-12-31 | CN¥468.65 Million ≈ $68.58 Million |
CN¥526.15K ≈ $76.99K |
0.001x | -97.05% |
| 2002-12-31 | CN¥399.62 Million ≈ $58.48 Million |
CN¥15.19 Million ≈ $2.22 Million |
0.038x | +143.44% |
| 2001-12-31 | CN¥134.77 Million ≈ $19.72 Million |
CN¥-11.80 Million ≈ $-1.73 Million |
-0.088x | -- |
About China National Medicines Corp Ltd
China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactures and sells new drugs; sells Chinese patent medicines drug sales and western medicines, and medical equipment; and offers dental academic services, warehousing, logistics and import and export agency services. It also serves hospitals, re… Read more